Boenning & Scattergood’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $509K | Buy |
5,798
+2
| +0% | +$176 | 0.08% | 248 |
|
|
2022
Q3 | $441K | Sell |
5,796
-7
| -0.1% | -$533 | 0.09% | 244 |
|
|
2022
Q2 | $491K | Buy |
5,803
+5
| +0.1% | +$423 | 0.09% | 227 |
|
|
2022
Q1 | $509K | Sell |
5,798
-948
| -14% | -$83.2K | 0.08% | 248 |
|
|
2021
Q4 | $590K | Buy |
6,746
+500
| +8% | +$43.7K | 0.09% | 226 |
|
|
2021
Q3 | $510K | Buy |
6,246
+750
| +14% | +$61.2K | 0.09% | 235 |
|
|
2021
Q2 | $501K | Hold |
5,496
| – | – | 0.09% | 243 |
|
|
2021
Q1 | $470K | Buy |
5,496
+293
| +6% | +$25.1K | 0.09% | 241 |
|
|
2020
Q4 | $491K | Buy |
5,203
+40
| +0.8% | +$3.78K | 0.1% | 209 |
|
|
2020
Q3 | $449K | Buy |
5,163
+56
| +1% | +$4.87K | 0.11% | 202 |
|
|
2020
Q2 | $446K | Sell |
5,107
-654
| -11% | -$57.1K | 0.12% | 190 |
|
|
2020
Q1 | $475K | Sell |
5,761
-543
| -9% | -$44.8K | 0.16% | 152 |
|
|
2019
Q4 | $597K | Hold |
6,304
| – | – | 0.15% | 162 |
|
|
2019
Q3 | $548K | Sell |
6,304
-4
| -0.1% | -$348 | 0.16% | 157 |
|
|
2019
Q2 | $576K | Sell |
6,308
-732
| -10% | -$66.8K | 0.17% | 152 |
|
|
2019
Q1 | $606K | Buy |
7,040
+17
| +0.2% | +$1.46K | 0.18% | 143 |
|
|
2018
Q4 | $540K | Hold |
7,023
| – | – | 0.19% | 145 |
|
|
2018
Q3 | $542K | Buy |
7,023
+1,395
| +25% | +$108K | 0.17% | 151 |
|
|
2018
Q2 | $381K | Buy |
+5,628
| New | +$381K | 0.13% | 197 |
|